Foreword
Chem Pharm Bull (Tokyo)
.
2022;70(5):309.
doi: 10.1248/cpb.c22-ctf7005.
Authors
Tatsuhiro Ishida
1
,
Kentaro Kogure
2
,
Masanori Tachikawa
3
,
Kazuhiko Baba
4
Affiliations
1
Department of Pharmacokinetics and Biopharmaceutics, Graduate School of Biomedical Sciences, Tokushima University.
2
Department of Pharmaceutical Health Chemistry, Graduate School of Biomedical Sciences, Tokushima University.
3
Department of Theoretical Chemistry for Drug Discovery, Graduate School of Biomedical Sciences, Tokushima University.
4
Formulation Research Laboratory, CMC Division, Taiho Pharmaceutical Co., Ltd.
PMID:
35491184
DOI:
10.1248/cpb.c22-ctf7005
No abstract available